You are here

Cancer Biotherapy and Radiopharmaceuticals

Cancer Biotherapy and Radiopharmaceuticals

Published in Association with Mary Ann Liebert

eISSN: 15578852 | ISSN: 10849785 | Current volume: 40 | Current issue: 8 Frequency: Not Yet Specified
This peer-reviewed journal provides cutting-edge research on therapeutic investigations and advancements in radioimmunotherapy for treating cancer. It is the only journal with a specific focus on cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies. The journal includes extensive reporting on advancements in radioimmunotherapy and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments.

Cancer Biotherapy and Radiopharmaceuticals provides peer-reviewed research on cutting-edge therapeutic investigations and advancements in all aspects of radioligand therapy for treating cancer. The manuscripts describing biotherapy (immunotherapy, antibody drug conjugates, cytokine therapy, cancer gene therapy and cell-based therapies) will be considered only if biotherapy is used in combination with or as a comparator for radionuclide therapy. In addition, the manuscripts describing translation of radionuclide therapy approach into non-oncological indications such as infections, autoimmune disease, cardiology etc. will also be considered. 

 

Cancer Biotherapy and Radiopharmaceuticals coverage includes:

 

  • Radiolabeled small molecules
  • Radiolabeled peptides
  • Radiolabeled antibodies and other large biological molecules
  • Radiolabeled nanoparticles
  • Radiolabeled DNA, RNA and aptamers

 

Audience: Oncologists, cardiologists, surgeons, nuclear medicine researchers, radiologists, cancer researchers, pathologists, and epidemiologists, among others.

 

By integrating perspectives from wide range of clinical disciplines, radiochemistry, nuclear medicine, and molecular biology, Cancer Biotherapy and Radiopharmaceuticals advances the field of targeted radioligand therapeutics and promotes their translation into effective, patient-centered treatments.

Editor-in-Chief
Ekaterina Dadachova, PhD University of Saskatchewan, Saskatoon, SK, Canada
Associate Editor
M R A Pillai, PhD, DSC Molecular Group Of Companies, Ernakulam Kerala, India
Associate Editors for Asia
Xiangya Ding, PhD Nanjing Medical University, Jiangsu, China
Editorial Board Members
Diane Abou, PhD Washington University School Of Medicine, Saint Louis, MO, USA
Guus Ams Van Dongen, PhD Vu University Amsterdam, Amsterdam, Netherlands
Carolyn J Anderson, PhD University of Missouri, Columbia, MO, USA
Christina M Annunziata, MD, PhD Center For Cancer Research, Bethesda, MD, USA
Joseph J Barchi, JR, PhD National Cancer Institute, Frederick, MD, USA
Benjamin Bonavida, MD Univ Of California Los Angeles, Los Angeles, CA, USA
Eszter Boros Stony Brook University, Stony Brook, NY, USA
Francesco Cicone, MD, PhD Magna Graecia University of Catanzaro, Catanzaro, Italy
Karen Cloud-Hansen Brookfield, WI, USA
Cathy S Cutler, PhD Brookhaven National Laboratory, Upton, NY, USA
Freddy Escorcia, MD, PhD National Cancer Institute, Bethesda, MD, USA
Luca Filippi, MD Policlinico Tor Vergata Univ Hospital, Rome, Italy
Darrell R Fisher, PhD Versant Med Physics&Radiation Safety, Richland, WA, USA
Jean-Francois Gestin, PhD Institut De Recherche Therapeutique De L Universite De Nantes, Nantes, France
Seigo Kinuya, MD Kanazawa University Grad Sch Med Sci, Kanazawa, Japan
Shweta Kotian, PhD U. S. Food And Drug Administration, Silver Spring, MD, USA
Suzanne E Lapi, PhD University of Alabama at Birmingham, Birmingham, AL, USA
Jason Lewis, PhD Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Madhava B Mallia, PhD Homi Bhabha National Institute, Mumbai, India
Ruby Meredith Univ Alabama @Birmingham, Birmingham, AL, USA
Yubin Miao, PhD Univ Of Colorado Denver, Aurora, CO, USA
Jessie R Nedrow, PhD University Of Pittsburgh, New Rochelle, NY, USA
Thomas P Quinn, PhD University of Missouri, Columbia, MO, USA
Gregory Ravizzini, MD The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Sangeeta Ray, PhD Johns Hopkins University School of Medicine, Baltimore, MD, USA
Raymond M Reilly, PhD University of Toronto, Toronto, ON, Canada
Domenico Rubello Santa Maria della Misericordia Hospital, Italy
Orazio Schillaci, MD, PhD University of Rome Tor Vergata, Rome, Italy
Andrew M Scott, MD Olivia Newton-John Cancer Research Institute, Heidelberg Vc, Australia
Maulin Shah, PhD Enviro Technology Limited, Gujarat, India
Deedee K Smart, MD, PhD National Cancer Institute, Bethesda, MD, USA
Daniel Thorek, PhD Washington University School Of Medicine, Saint Louis, MO, USA
Kwong Y Tsang, PhD Precision Biologics Inc, Rockville, MD, USA
J Harvey Turner, MD Fiona Stanley Fremantle Hospitals, Murdoch Wa, Australia
Nerissa T Viola, PhD Wayne State University, Detroit, MI, USA
Anna M Wu, PhD UCLA School of Medicine, Los Angeles, CA, USA
Zhi Yang, PhD Peking University, Beijing, China
  • BIOSIS database
  • CAB Abstracts
  • CABI: Global Health
  • Chemical Abstracts
  • Clarivate Analytics: Biological Abstracts
  • Clarivate Analytics: Current Contents - Clinical Medicine
  • Clarivate Analytics: Current Contents - Life Sciences
  • EBSCO
  • EMBASE/Excerpta Medica
  • EMCare
  • Journal Citation Reports/Science Edition
  • MEDLINE/PubMed (NLM)
  • ProQuest
  • Prous Science Integrity®
  • PubMed: PubMed Central (PMC)
  • Scopus
  • Individual Subscription, E-access


    Individual Subscription, Combined (Print & E-access)


    Institutional Subscription, E-access


    Institutional Subscription & Backfile Lease, E-access Plus Backfile (All Online Content)


    Institutional Subscription, Print Only


    Institutional Subscription, Combined (Print & E-access)


    Institutional Subscription & Backfile Lease, Combined Plus Backfile (Current Volume Print & All Online Content)


    Individual, Single Print Issue


    Institutional, Single Print Issue